NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Thanks John.



I found this section particularly intriguing.

To date 48% of all patients with Glioblastoma multiforme Stage IV went in complete and long-lasting remission. This is remarkable, given that statistics from the medical literature indicate that with standard treatment, about 72% of all patients who have been diagnosed with Glioblastoma multiforme Stage IV die within the first year of diagnosis and only 1% survive three years.

These outcomes reflect the positive survival rates frequently seen in the patients at the Medical Center Cologne. Dendritic cell therapy has been an integral aspect of Dr. Gorter’s treatment for more than 10 years.